SCHEMBL13628885

SCHEMBL13628885

COC(=O)C1CCCc2nnc(-c3ccccc3)n21

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.43
KMT2A Q03164 2/20 0.41
ADRB2 P07550 1/20 0.39
XDH P47989 1/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A2 P23975 1/20 0.39
CYP3A4 P08684 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
FKBP1A P62942 1/20 0.38
MMP2 P08253 1/20 0.38
ANPEP P15144 1/20 0.38
LTA4H P09960 2/20 0.37
ALOX5 P09917 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4511545 0.92 KMT2A (0.45) HPGDKMT2AADRB2XDHSLC6A4
SCHEMBL4515035 0.72 FKBP1A (0.44) HPGDKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL30813921 0.69 TSHR (0.43) KMT2AKDM4EALDH1A1FKBP1ALMNA
SCHEMBL19584148 0.69 TSHR (0.43) KMT2AKDM4EALDH1A1FKBP1ALMNA
SCHEMBL30813083 0.67 MMP2 (0.35) KMT2ACYP3A4ALDH1A1FKBP1AMMP2
SCHEMBL19583645 0.67 MMP2 (0.35) KMT2ACYP3A4ALDH1A1FKBP1AMMP2
SCHEMBL19583679 0.67 MMP2 (0.35) KMT2ACYP3A4ALDH1A1FKBP1AMMP2
SCHEMBL30813702 0.65 PREP (0.54) KMT2AALDH1A1
SCHEMBL22452838 0.65 CAPN1 (0.58) KMT2AALDH1A1FKBP1A
SCHEMBL28681218 0.65 CAPN1 (0.58) KMT2AALDH1A1FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618983-B2 Bicyclic triazole α4 integrin inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2009-11-17 US disclosed
US-7618983-B2 Bicyclic triazole α4 integrin inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2009-11-17 US disclosed